Skip to main content
Normal View

Dáil Éireann debate -
Tuesday, 30 Sep 2003

Vol. 571 No. 1

Written Answers. - Cancer Incidence.

Bernard Allen

Question:

898 Mr. Allen asked the Minister for Health and Children if he will make a statement on a situation where thousands of Irish men will die of prostate cancer while his Department awaits the results of a European study on screening, in view of the fact that his Department has blocked population based screening until the outcome of the European study and that approximately 520 men die of prostate cancer every year here. [20176/03]

There are approximately 7,800 deaths annually from cancer, of which approximately 540 are due to cancer of the prostate. I do not accept that my Department has blocked population screening until the outcome of the European study referred to by the Deputy. As the Deputy is aware, a new national cancer strategy is currently being developed by the National Cancer Forum in conjunction with my Department. As part of this work, a sub-group of the National Cancer Forum was established on generic screening. This multidisciplinary group has reviewed all issues relating to screening, including examining specific diseases such as prostate and colorectal cancer. As regards screening for prostate cancer in particular, the group recommended that there is currently insufficient evidence to recommend the introduction of a population based prostate screening programme in this country. The group recommended that this issue should be reassessed when the results are available from randomised trials currently being conducted. The group's recommendations will inform the development of the new national cancer strategy.

I advise the Deputy of draft proposals from the European Commission for a Council of Europe recommendation on cancer screening. The proposal, which is expected to be accepted by the Health Council before the end of the year, provides a framework for consideration by member states of cancer screening programmes. The proposals do not provide for specific recommendations in respect of screening for prostate cancer. The proposals also recognise that ethical, legal, social, medical, organisational and economic aspects have to be considered before decisions can be made on the implementation of cancer screening programmes. Decisions should also be based on priority setting for healthcare resources in each member state.
Top
Share